Pilot Study of ORG 25935 Modulation of Ketamine-Induced Behavioral and Cognitive Effects in Healthy Male Subjects.

Trial Profile

Pilot Study of ORG 25935 Modulation of Ketamine-Induced Behavioral and Cognitive Effects in Healthy Male Subjects.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs ORG 25935 (Primary) ; Ketamine
  • Indications Schizophrenia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Dec 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 01 Dec 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 27 Nov 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top